Research article
Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy
Jacques Cantin, Hugh Scarth, Mark Levine, Maria Hugi and The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
CMAJ July 24, 2001 165 (2) 166-173;
Jacques Cantin
Dr. Cantin is Associate Professor at the University of Montreal and is with the Centre hospitalier de l'Université de Montréal, Montreal, Que.; Dr. Scarth is Assistant Professor, Department of Surgery, Dalhousie University, and is with the Atlantic Health Sciences Corporation, Saint John, NB; Dr. Levine is Professor in the Departments of Medicine and Clinical Epidemiology and Biostatistics, McMaster University, and is the Buffet Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ont.; and Dr. Hugi is with Providence Health Care, Vancouver, BC. Dr. Mark Levine (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont. Dr. David M. Bowman (Manitoba Cancer Treatment and Research Foundation), Manitoba Cancer Treatment and Research Foundation, Winnipeg, Man.; Dr. Judy Caines (Federal/Provincial/Territorial Advisory Committee on Health Services), Nova Scotia Cancer Centre, Halifax, NS; Dr. Jacques Cantin (Royal College of Physicians and Surgeons of Canada), Centre hospitalier de l'Université de Montréal, Montreal, Que.; Ms. Chris Emery (Canadian Nurses Association), BC Cancer Agency, Delta, BC; Dr. Eva Grunfeld (College of Family Physicians of Canada), Ottawa Regional Cancer Centre, Ottawa, Ont.; Dr. Maria R. Hugi (Canadian Breast Cancer Network), Providence Health Care, Vancouver, BC; Dr. Alan W. Lees (Alberta Cancer Board), Cross Cancer Institute, Edmongon, Alta.; Ms. Sabina Mallard (Canadian Breast Cancer Network), consumer representative, Stratford, PEI; Dr. Mohamed Mohamed (Saskatchewan Cancer Foundation), Saskatoon Cancer Centre, Saskatoon, Sask.; Dr. Ivo A. Olivotto (BC Cancer Agency), Vancouver Island Cancer Centre and University of British Columbia, Victoria, BC; Dr. Leonard Reyno (Cancer Care Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; Dr. Carol Sawka (Cancer Care Ontario), Toronto Sunnybrook Regional Cancer Centre, Toronto, Ont.; Dr. Hugh Scarth (Atlantic Health Sciences Corporation), Saint John Regional Hospital, Saint John, NB; Ms. Donna Seymour (Health Canada), Adult Health Division, Centre for Chronic Disease and Control, Health Canada, Ottawa, Ont.; Dr. S. Kishore Thain (Newfoundland Cancer Treatment and Research Foundation), Dr. H.B. Murphy Cancer Centre, St. John's, Nfld.; Dr. Timothy Whelan (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont.; and, at the time of writing, Dr. Jean Deschênes (Comité consultatif sur le cancer du Québec), Jewish General Hospital, Quebec, Que.; Dr. L. Arthur Firth (Saskatchewan Cancer Foundation), Allan Blair Cancer Centre, Regina, Sask.; Dr. Maureen C. Nolan (Cancer Treatment and Research Foundation of Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; and Dr. John W. Sellors (College of Family Physicians of Canada), McMaster University, Hamilton, Ont.
Hugh Scarth
Dr. Cantin is Associate Professor at the University of Montreal and is with the Centre hospitalier de l'Université de Montréal, Montreal, Que.; Dr. Scarth is Assistant Professor, Department of Surgery, Dalhousie University, and is with the Atlantic Health Sciences Corporation, Saint John, NB; Dr. Levine is Professor in the Departments of Medicine and Clinical Epidemiology and Biostatistics, McMaster University, and is the Buffet Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ont.; and Dr. Hugi is with Providence Health Care, Vancouver, BC. Dr. Mark Levine (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont. Dr. David M. Bowman (Manitoba Cancer Treatment and Research Foundation), Manitoba Cancer Treatment and Research Foundation, Winnipeg, Man.; Dr. Judy Caines (Federal/Provincial/Territorial Advisory Committee on Health Services), Nova Scotia Cancer Centre, Halifax, NS; Dr. Jacques Cantin (Royal College of Physicians and Surgeons of Canada), Centre hospitalier de l'Université de Montréal, Montreal, Que.; Ms. Chris Emery (Canadian Nurses Association), BC Cancer Agency, Delta, BC; Dr. Eva Grunfeld (College of Family Physicians of Canada), Ottawa Regional Cancer Centre, Ottawa, Ont.; Dr. Maria R. Hugi (Canadian Breast Cancer Network), Providence Health Care, Vancouver, BC; Dr. Alan W. Lees (Alberta Cancer Board), Cross Cancer Institute, Edmongon, Alta.; Ms. Sabina Mallard (Canadian Breast Cancer Network), consumer representative, Stratford, PEI; Dr. Mohamed Mohamed (Saskatchewan Cancer Foundation), Saskatoon Cancer Centre, Saskatoon, Sask.; Dr. Ivo A. Olivotto (BC Cancer Agency), Vancouver Island Cancer Centre and University of British Columbia, Victoria, BC; Dr. Leonard Reyno (Cancer Care Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; Dr. Carol Sawka (Cancer Care Ontario), Toronto Sunnybrook Regional Cancer Centre, Toronto, Ont.; Dr. Hugh Scarth (Atlantic Health Sciences Corporation), Saint John Regional Hospital, Saint John, NB; Ms. Donna Seymour (Health Canada), Adult Health Division, Centre for Chronic Disease and Control, Health Canada, Ottawa, Ont.; Dr. S. Kishore Thain (Newfoundland Cancer Treatment and Research Foundation), Dr. H.B. Murphy Cancer Centre, St. John's, Nfld.; Dr. Timothy Whelan (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont.; and, at the time of writing, Dr. Jean Deschênes (Comité consultatif sur le cancer du Québec), Jewish General Hospital, Quebec, Que.; Dr. L. Arthur Firth (Saskatchewan Cancer Foundation), Allan Blair Cancer Centre, Regina, Sask.; Dr. Maureen C. Nolan (Cancer Treatment and Research Foundation of Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; and Dr. John W. Sellors (College of Family Physicians of Canada), McMaster University, Hamilton, Ont.
Mark Levine
Dr. Cantin is Associate Professor at the University of Montreal and is with the Centre hospitalier de l'Université de Montréal, Montreal, Que.; Dr. Scarth is Assistant Professor, Department of Surgery, Dalhousie University, and is with the Atlantic Health Sciences Corporation, Saint John, NB; Dr. Levine is Professor in the Departments of Medicine and Clinical Epidemiology and Biostatistics, McMaster University, and is the Buffet Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ont.; and Dr. Hugi is with Providence Health Care, Vancouver, BC. Dr. Mark Levine (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont. Dr. David M. Bowman (Manitoba Cancer Treatment and Research Foundation), Manitoba Cancer Treatment and Research Foundation, Winnipeg, Man.; Dr. Judy Caines (Federal/Provincial/Territorial Advisory Committee on Health Services), Nova Scotia Cancer Centre, Halifax, NS; Dr. Jacques Cantin (Royal College of Physicians and Surgeons of Canada), Centre hospitalier de l'Université de Montréal, Montreal, Que.; Ms. Chris Emery (Canadian Nurses Association), BC Cancer Agency, Delta, BC; Dr. Eva Grunfeld (College of Family Physicians of Canada), Ottawa Regional Cancer Centre, Ottawa, Ont.; Dr. Maria R. Hugi (Canadian Breast Cancer Network), Providence Health Care, Vancouver, BC; Dr. Alan W. Lees (Alberta Cancer Board), Cross Cancer Institute, Edmongon, Alta.; Ms. Sabina Mallard (Canadian Breast Cancer Network), consumer representative, Stratford, PEI; Dr. Mohamed Mohamed (Saskatchewan Cancer Foundation), Saskatoon Cancer Centre, Saskatoon, Sask.; Dr. Ivo A. Olivotto (BC Cancer Agency), Vancouver Island Cancer Centre and University of British Columbia, Victoria, BC; Dr. Leonard Reyno (Cancer Care Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; Dr. Carol Sawka (Cancer Care Ontario), Toronto Sunnybrook Regional Cancer Centre, Toronto, Ont.; Dr. Hugh Scarth (Atlantic Health Sciences Corporation), Saint John Regional Hospital, Saint John, NB; Ms. Donna Seymour (Health Canada), Adult Health Division, Centre for Chronic Disease and Control, Health Canada, Ottawa, Ont.; Dr. S. Kishore Thain (Newfoundland Cancer Treatment and Research Foundation), Dr. H.B. Murphy Cancer Centre, St. John's, Nfld.; Dr. Timothy Whelan (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont.; and, at the time of writing, Dr. Jean Deschênes (Comité consultatif sur le cancer du Québec), Jewish General Hospital, Quebec, Que.; Dr. L. Arthur Firth (Saskatchewan Cancer Foundation), Allan Blair Cancer Centre, Regina, Sask.; Dr. Maureen C. Nolan (Cancer Treatment and Research Foundation of Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; and Dr. John W. Sellors (College of Family Physicians of Canada), McMaster University, Hamilton, Ont.
Maria Hugi
Dr. Cantin is Associate Professor at the University of Montreal and is with the Centre hospitalier de l'Université de Montréal, Montreal, Que.; Dr. Scarth is Assistant Professor, Department of Surgery, Dalhousie University, and is with the Atlantic Health Sciences Corporation, Saint John, NB; Dr. Levine is Professor in the Departments of Medicine and Clinical Epidemiology and Biostatistics, McMaster University, and is the Buffet Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ont.; and Dr. Hugi is with Providence Health Care, Vancouver, BC. Dr. Mark Levine (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont. Dr. David M. Bowman (Manitoba Cancer Treatment and Research Foundation), Manitoba Cancer Treatment and Research Foundation, Winnipeg, Man.; Dr. Judy Caines (Federal/Provincial/Territorial Advisory Committee on Health Services), Nova Scotia Cancer Centre, Halifax, NS; Dr. Jacques Cantin (Royal College of Physicians and Surgeons of Canada), Centre hospitalier de l'Université de Montréal, Montreal, Que.; Ms. Chris Emery (Canadian Nurses Association), BC Cancer Agency, Delta, BC; Dr. Eva Grunfeld (College of Family Physicians of Canada), Ottawa Regional Cancer Centre, Ottawa, Ont.; Dr. Maria R. Hugi (Canadian Breast Cancer Network), Providence Health Care, Vancouver, BC; Dr. Alan W. Lees (Alberta Cancer Board), Cross Cancer Institute, Edmongon, Alta.; Ms. Sabina Mallard (Canadian Breast Cancer Network), consumer representative, Stratford, PEI; Dr. Mohamed Mohamed (Saskatchewan Cancer Foundation), Saskatoon Cancer Centre, Saskatoon, Sask.; Dr. Ivo A. Olivotto (BC Cancer Agency), Vancouver Island Cancer Centre and University of British Columbia, Victoria, BC; Dr. Leonard Reyno (Cancer Care Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; Dr. Carol Sawka (Cancer Care Ontario), Toronto Sunnybrook Regional Cancer Centre, Toronto, Ont.; Dr. Hugh Scarth (Atlantic Health Sciences Corporation), Saint John Regional Hospital, Saint John, NB; Ms. Donna Seymour (Health Canada), Adult Health Division, Centre for Chronic Disease and Control, Health Canada, Ottawa, Ont.; Dr. S. Kishore Thain (Newfoundland Cancer Treatment and Research Foundation), Dr. H.B. Murphy Cancer Centre, St. John's, Nfld.; Dr. Timothy Whelan (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont.; and, at the time of writing, Dr. Jean Deschênes (Comité consultatif sur le cancer du Québec), Jewish General Hospital, Quebec, Que.; Dr. L. Arthur Firth (Saskatchewan Cancer Foundation), Allan Blair Cancer Centre, Regina, Sask.; Dr. Maureen C. Nolan (Cancer Treatment and Research Foundation of Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; and Dr. John W. Sellors (College of Family Physicians of Canada), McMaster University, Hamilton, Ont.
Dr. Cantin is Associate Professor at the University of Montreal and is with the Centre hospitalier de l'Université de Montréal, Montreal, Que.; Dr. Scarth is Assistant Professor, Department of Surgery, Dalhousie University, and is with the Atlantic Health Sciences Corporation, Saint John, NB; Dr. Levine is Professor in the Departments of Medicine and Clinical Epidemiology and Biostatistics, McMaster University, and is the Buffet Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ont.; and Dr. Hugi is with Providence Health Care, Vancouver, BC. Dr. Mark Levine (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont. Dr. David M. Bowman (Manitoba Cancer Treatment and Research Foundation), Manitoba Cancer Treatment and Research Foundation, Winnipeg, Man.; Dr. Judy Caines (Federal/Provincial/Territorial Advisory Committee on Health Services), Nova Scotia Cancer Centre, Halifax, NS; Dr. Jacques Cantin (Royal College of Physicians and Surgeons of Canada), Centre hospitalier de l'Université de Montréal, Montreal, Que.; Ms. Chris Emery (Canadian Nurses Association), BC Cancer Agency, Delta, BC; Dr. Eva Grunfeld (College of Family Physicians of Canada), Ottawa Regional Cancer Centre, Ottawa, Ont.; Dr. Maria R. Hugi (Canadian Breast Cancer Network), Providence Health Care, Vancouver, BC; Dr. Alan W. Lees (Alberta Cancer Board), Cross Cancer Institute, Edmongon, Alta.; Ms. Sabina Mallard (Canadian Breast Cancer Network), consumer representative, Stratford, PEI; Dr. Mohamed Mohamed (Saskatchewan Cancer Foundation), Saskatoon Cancer Centre, Saskatoon, Sask.; Dr. Ivo A. Olivotto (BC Cancer Agency), Vancouver Island Cancer Centre and University of British Columbia, Victoria, BC; Dr. Leonard Reyno (Cancer Care Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; Dr. Carol Sawka (Cancer Care Ontario), Toronto Sunnybrook Regional Cancer Centre, Toronto, Ont.; Dr. Hugh Scarth (Atlantic Health Sciences Corporation), Saint John Regional Hospital, Saint John, NB; Ms. Donna Seymour (Health Canada), Adult Health Division, Centre for Chronic Disease and Control, Health Canada, Ottawa, Ont.; Dr. S. Kishore Thain (Newfoundland Cancer Treatment and Research Foundation), Dr. H.B. Murphy Cancer Centre, St. John's, Nfld.; Dr. Timothy Whelan (Cancer Care Ontario), Hamilton Regional Cancer Centre and McMaster University, Hamilton, Ont.; and, at the time of writing, Dr. Jean Deschênes (Comité consultatif sur le cancer du Québec), Jewish General Hospital, Quebec, Que.; Dr. L. Arthur Firth (Saskatchewan Cancer Foundation), Allan Blair Cancer Centre, Regina, Sask.; Dr. Maureen C. Nolan (Cancer Treatment and Research Foundation of Nova Scotia), Nova Scotia Cancer Centre, Halifax, NS; and Dr. John W. Sellors (College of Family Physicians of Canada), McMaster University, Hamilton, Ont.
Data supplements
Également disponible :
-
Guide n<SUPo13. La biopsie du ganglion lymphatique sentinelle (version française)
-
La biopsie du ganglion lymphatique sentinelle (guide à l'intention des femmes et de leurs médecins)
Pour consulter l'index complet des Guides de pratique clinique pour la prise en charge et le traitement du cancer du sein, cliquer ici.
-
Related Articles
In this issue
Article tools
Respond to this article
Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy
Jacques Cantin, Hugh Scarth, Mark Levine, Maria Hugi, The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
CMAJ Jul 2001, 165 (2) 166-173;
Jump to section
Related Articles
Cited By...
- Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer
- American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
- Surgical management of early stage invasive breast cancer: a practice guideline
- Practice patterns of lymph-node mapping and sentinel-node biopsy for breast cancer in British Columbia
- Breast cancer guidelines
- Correction